Pure eye muscle involvement in endocrine orbitopathy

European Neurology

Volumn 60, Issue 2, 2008, Pages 67-72

  Gerlach, Marion ^a   Ferbert, Andreas ^a  

^a KLINIKUM KASSEL   (Germany)

Author keywords

Endocrine orbitopathy; Extra ocular eye muscle dysfunction; Proptosis; Thyroid stimulating antibodies; Vertical diplopia

Indexed keywords

CORTISONE; RADIOACTIVE IODINE; THYROID HORMONE; THYROID STIMULATING IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EYE EXAMINATION; EYE MOVEMENT; HORMONE BLOOD LEVEL; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS;

ADULT; AGED; AUTOANTIBODIES; CORTISONE; DIAGNOSIS, DIFFERENTIAL; DIPLOPIA; FEMALE; FOLLOW-UP STUDIES; GRANULOMA, PLASMA CELL, ORBITAL; GRAVES OPHTHALMOPATHY; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; IMMUNOSUPPRESSIVE AGENTS; IODIDE PEROXIDASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OCULOMOTOR MUSCLES; ORBIT; RECEPTORS, THYROTROPIN; THYROGLOBULIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48249134386     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000131894     Document Type: Article

References (14)

1. Heufelder AE, Spitzweg C: Pathogenese der immunogenen Hyperthyreose und endokrinen Orbitopathie. Internist 1998;39:599-606.
2. Fung S, Malhotra R: Thyroid orbitopathy. Aust Fam Physician 2003;32:615-620.
3. Goh SY, Ho SC: Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease. Clin Endocrinol 2004;60:600-607.
4. Förster G, Kahaly G: Endokrine Orbitopathie. Med Klin 1998;93:365-373.
5. Weetman AP: Graves' disease. N Engl J Med 2000;343:1236-1248.
6. Prummel MF, Bakker A: Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. Eur J Endocrinol 2003;148:491-495.
7. Patrinely JR, Osborn AG: Computed tomographic features of nonthyroid extraocular muscle enlargement. Ophthalmology 1990;97:4-5.
8. Villadolid MC, Yokoyama N: Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance. J Clin Endocrinol Metab 1995;80:2830-2833.
9. Berkhoff M, Sturzenegger M: Okuläre Myositis. Nervenarzt 1997;68:792-800.
10. Shambal S, Lindner A: Successful treatment of orbital myositis with intravenous immunoglobulins. Muscle Nerve 1998;21:1359-1360.
11. Simon GJ, Syed HM: Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy. Am J Ophthalmol 2004;137:1145-1147.
12. Yu Wai Man CY, Chinnery PF: Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders. Neuromuscular Disord 2004;15:17-23.
13. Kloprogge SJ, Busuttil BE: TSH receptor protein is selectively expressed in normal human extraocular muscle. Muscle Nerve 2005;32:95-98.
14. Mizokami T, Salvi M: Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon? J Endocrinol Invest 2004;27:221-229.